Trial
NCT03021317
Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
—
Condition
Multiple Sclerosis
Intervention
ACTHar
Why stopped
Terminated early due to lack of resources.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-16